We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+585.67%
AUM
$246M
AUM Growth
+$12.4M
Cap. Flow
+$4M
Cap. Flow %
1.62%
Top 10 Hldgs %
38.42%
Holding
118
New
7
Increased
68
Reduced
27
Closed
6
Avg Time Held
11.5 quarters
Top 10 Avg Time Held
10.6 quarters
Top 20 Avg Time Held
11.6 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.89%
2 Technology 18.3%
3 Financials 16.78%
4 Communication Services 11.51%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SCHD icon
26
Schwab US Dividend Equity ETF
SCHD
$110B
$2.85M 1.16%
161,052
-1,455
-0.9% -$25.6K
2018 Q1
5 quarters
IBM icon
27
IBM
IBM
$214B
$2.6M 1.06%
19,712
+696
+4% +$91.4K
2019 Q1
1 quarter
SCHM icon
28
Schwab US Mid-Cap ETF
SCHM
$14.6B
$2.56M 1.04%
134,484
+5,778
+4% +$108K
2015 Q1
17 quarters
SCHE icon
29
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$2.3M 0.93%
87,495
+1,571
+2% +$40.7K
2016 Q3
11 quarters
INTC icon
30
Intel
INTC
$553B
$2.25M 0.91%
46,971
-1,298
-3% -$64.4K
2014 Q1
21 quarters
SPY icon
31
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$2.2M 0.89%
7,503
– –
2014 Q1
21 quarters
SCHA icon
32
Schwab U.S Small- Cap ETF
SCHA
$21.8B
$2.2M 0.89%
122,908
-2,228
-2% -$39.4K
2014 Q1
21 quarters
DEO icon
33
Diageo
DEO
$48.2B
$2.15M 0.87%
12,480
+10
+0.1% +$1.68K
2014 Q1
21 quarters
BND icon
34
Vanguard Total Bond Market
BND
$162B
$2.09M 0.85%
25,195
+2,275
+10% +$185K
2014 Q4
18 quarters
PRAH
35
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.96M 0.8%
19,725
+355
+2% +$33.9K
2017 Q4
6 quarters
AMD icon
36
Advanced Micro Devices
AMD
$993B
$1.93M 0.78%
+63,470
New +$1.81M
2019 Q2
0 quarters
EEM icon
37
iShares MSCI Emerging Markets ETF
EEM
$31B
$1.9M 0.77%
44,162
-383
-0.9% -$16.3K
2017 Q1
9 quarters
UNH icon
38
UnitedHealth
UNH
$340B
$1.88M 0.76%
7,687
+891
+13% +$214K
2018 Q3
3 quarters
T icon
39
AT&T
T
$152B
$1.72M 0.7%
67,879
+11,781
+21% +$283K
2016 Q2
12 quarters
VNQI icon
40
Vanguard Global ex-US Real Estate ETF
VNQI
$3.25B
$1.71M 0.7%
29,054
+1,965
+7% +$115K
2014 Q1
21 quarters
UPS icon
41
United Parcel Service
UPS
$80.5B
$1.69M 0.68%
16,315
+30
+0.2% +$3.12K
2018 Q1
5 quarters
LULU icon
42
lululemon athletica
LULU
$10.9B
$1.67M 0.68%
9,240
+680
+8% +$118K
2018 Q4
2 quarters
EFA icon
43
iShares MSCI EAFE ETF
EFA
$76.4B
$1.6M 0.65%
24,385
-289
-1% -$18.9K
2017 Q4
6 quarters
BSX icon
44
Boston Scientific
BSX
$61.9B
$1.58M 0.64%
36,680
+9,420
+35% +$362K
2019 Q1
1 quarter
SVC
45
Service Properties Trust
SVC
$926M
$1.53M 0.62%
12,248
+575
+5% +$73.7K
2014 Q1
21 quarters
IWM icon
46
iShares Russell 2000 ETF
IWM
$78.5B
$1.53M 0.62%
9,816
+104
+1% +$16K
2016 Q1
13 quarters
NVDA icon
47
NVIDIA
NVDA
$5.54T
$1.53M 0.62%
371,640
+2,000
+0.5% +$8.29K
2016 Q1
13 quarters
KRE icon
48
State Street SPDR S&P Regional Banking ETF
KRE
$3.59B
$1.51M 0.61%
28,297
+2
+0% +$107
2016 Q4
10 quarters
GPN icon
49
Global Payments
GPN
$21.8B
$1.49M 0.61%
9,315
+150
+2% +$22.3K
2018 Q1
5 quarters
XOM icon
50
ExxonMobil
XOM
$695B
$1.35M 0.55%
17,623
+567
+3% +$43.9K
2014 Q1
21 quarters

Similar funds

Fagan Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Fagan Associates held 118 positions worth $246M, up 5.3% from $234M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Fagan Associates's Q2 2019 filing shows 7 new, 68 increased, 27 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 63,470 shares worth $1.93M. The largest sale was Regeneron Pharmaceuticals, an estimated $2.26M.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Fagan Associates's largest Q2 2019 buy was Advanced Micro Devices: 63,470 shares worth $1.93M.
  • Fagan Associates added most to Walt Disney in Q2 2019, an estimated $475K increase.
  • Fagan Associates's biggest Q2 2019 reduction was Intel, cutting an estimated $64.4K.
  • Fagan Associates fully exited Regeneron Pharmaceuticals in Q2 2019, selling an estimated $2.26M.
  • Fagan Associates's ten largest holdings make up 38% of its $246M portfolio in Q2 2019.
  • Fagan Associates opened 7 new positions and closed 6 in Q2 2019.
  • Fagan Associates's portfolio value rose 5.3% quarter-over-quarter to $246M.

Based on Fagan Associates's 13F filing for Q2 2019, filed 12 Jul 2019.